We applied the miRCURY LNA microarray platform to generate miRNA expression profiles of breast cancer tissue and normal adjacent breast tissue to identify possible new biomarkers for breast cancer 9.
A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.
Mirxes, a leading Singapore-based cancer detection firm, has secured $40 million in financing from CBC Group's R-Bridge Fund to enhance its innovative miRNA technology platform. The investment aims to ...
Blood tests have revealed research results that can increase the accuracy of breast cancer diagnosis.A joint research team of professors Kim Seung-il and Kim ...
Particularly microRNAs have emerged as informative biomarkers of cell status and function. Sensitive, specific and unbiased microRNA profiling in liquid biopsies – from serum and plasma, to urine and ...